Auris, nasus, larynx
-
Auris, nasus, larynx · Feb 2016
Association of serum 25-hydroxyvitamin D with serum IgE levels in Korean adults.
Studies about the association between vitamin D and allergic disease and the immune-modulatory function of vitamin D have increased in the recent years. However, not enough studies have been conducted for concrete conclusion about the association vitamin D and allergy. We investigate the association between serum immunoglobulin E (IgE) and serum 25-hydroxyvitamin D (25(OH)D) levels in Korean adults. ⋯ Serum 25(OH)D levels were positively associated with total IgE levels. Furthermore, the association between serum 25(OH)D and total IgE levels could vary depending on sex or allergic sensitization. But, the mean serum 25(OH)D level was lower in participants with asthma or atopic dermatitis history than participants without history of asthma or atopic dermatitis. Prospective further studies will be required to verify this discrepancy.
-
Auris, nasus, larynx · Feb 2016
Endoscopic submandibular gland resection preserving great auricular nerve and periaural sensation.
The preservation of periaural sensation is one of the most important things to improve the postoperative quality of life after performing the surgical procedures via retroauricular approach. The aim of this study is to describe the surgical technique of endoscopic submandibular gland (SMG) resection through the potential plane between great auricular nerve (GAN) and sternocleidomastoid muscle (sub-GAN dissection) and to evaluate its technical feasibility and advantage. ⋯ Linear hairline incision and sub-GAN dissection were feasible to acquire the sufficient working space for endoscopic SMG resection without sensory deterioration of GAN. This procedure may be useful to apply the surgery of other upper neck masses or thyroidectomy via retroauricular approach.
-
Auris, nasus, larynx · Oct 2015
Subglottic laryngitis--Changes in therapy approach over the past 20 years.
To show changes in the management of subglottic laryngitis over the last twenty years in Croatia. ⋯ Main novelties included the use of racemic epinephrine and downfall of antibiotic, antihistaminic and humidification therapy use, while corticosteroids remained the cornerstone in the treatment of moderately severe subglottic laryngitis. Differences between approaches among specialities are minimized during 20-year period.
-
Auris, nasus, larynx · Aug 2015
Quantitative analysis of facial palsy using a three-dimensional facial motion measurement system.
The prognosis for facial nerve palsy (FNP) depends on its severity. Currently, many clinicians use the Yanagihara, House-Brackmann, and/or Sunnybrook grading systems to assess FNP. Although these assessments are performed by experts, inter- and intra-observer disagreements have been demonstrated. The quantitative and objective analyses of the degree of FNP would be preferred to monitor functional changes and to plan and evaluate therapeutic interventions in patients with FNP. Numerous two-dimensional (2-D) assessments have been proposed, however, the limitations of 2-D assessment have been reported. The purpose of this study was to introduce a three-dimensional (3-D) image generation system for the analysis of facial nerve palsy (FNP) and to show the correlation between the severity of FNP assessed by this method and two conventional systems. ⋯ This objective method can produce consistent results that align with two conventional systems. Therefore, this method is ideally suited for use in a routine clinical setting.
-
Auris, nasus, larynx · Aug 2015
Comparative StudyComparison of facial synkinesis at 6 and 12 months after the onset of peripheral facial nerve palsy.
To investigate the time course of synkinesis as a sequela of facial nerve palsy so that we are able to determine an appropriate time for deciding the outcome of recovery in patients with facial nerve palsy. ⋯ From our results, synkinesis deteriorated after the 6th month from the onset of palsy. Therefore, we should follow up the degree of synkinesis until at least the 12th month, and the outcome of recovery in patients with facial synkinesis should be evaluated at least 12 months after the onset.